FDA Drug · D-0925-2018

Admelog Solostar (insulin lispro injection), 100 units/ mL (U-100) injection, packaged in 3mL prefilled pens, 1 pen per box, Rx only, Physician Sample - Not For Sale, Sanofi-Aventis U.S. LLC, Bridgewater, NJ 08807, NDC 0024-5925-00

Class II · Ongoing

Temperature Abuse: Product samples of Admelog may not have been shipped at proper temperature.

Affected lots / codes — check yours against thisLot #: 7F021B, Exp 6/30/20

Recalling firm: Sanofi-Aventis U.S. LLC, Bridgewater, NJ
Classification: Class II (temporary or reversible harm possible)
Status: Ongoing
Quantity: 3214 prefilled pens
Distribution: Nationwide
Recall initiated: July 5, 2018
Classified: July 16, 2018
Initiation: Voluntary: Firm initiated

Official source. This record is published by the U.S. FDA through the openFDA enforcement database. View the unmodified government record:
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0925-2018%22

Important. Recalls target specific lots and codes — compare the affected lots above against your own product. This page reproduces public FDA data for readability; EveryRecall is independent and not affiliated with the FDA.

Check this brand across all 8 databases →